Bengt Westermark

Bengt Westermark

Director/Board Member at MEDIVIR AB
81 year
Health Technology
Commercial Services
Consumer Services

Profile

Bengt Westermark is the founder of Mesenkia Therapeutics AB, serving as Chairman since 2023.
Current jobs include Independent Director at Medivir AB since 2017, Member of the Royal Swedish Academy of Sciences, Professor at the University of Uppsala since 2002, Member of the European Molecular Biology Organization, Member of the Royal Society of Sciences, and Member of The European Academy of Cancer Sciences.
Former jobs include Chairman-Research Board at The Swedish Cancer Society from 2003 to 2013, Independent Director at Medivir AB from 2017 to 2021, and Director at Hamlet BioPharma AB.

Bengt Westermark active positions

CompaniesPositionStart
MEDIVIR AB Director/Board Member 2016-12-31
Corporate Officer/Principal 1985-12-31
Corporate Officer/Principal -
European Molecular Biology Organization
Corporate Officer/Principal -
Royal Society of Sciences
Corporate Officer/Principal -
Corporate Officer/Principal -

Former positions of Bengt Westermark

CompaniesPositionEnd
MEDIVIR AB Director/Board Member 2021-05-04
The Swedish Cancer Society
Corporate Officer/Principal 2012-12-31
HAMLET PHARMA AB (PUBL) Director/Board Member -
See the detail of Bengt Westermark's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

85

1st degree connections

8

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies8

Health Technology

Commercial Services

Consumer Services

The Swedish Cancer Society

European Molecular Biology Organization

Health Technology

Royal Society of Sciences

Commercial Services

  1. Stock Market
  2. Insiders
  3. Bengt Westermark